Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2011

Open Access 01-10-2011 | Solicited Commentary

Immunogenicity of two different hepatitis B vaccine schedules

Authors: S. Y. Agladioglu, U. Beyazova, A. D. Camurdan, F. Sahin, A. Atak

Published in: Infection | Issue 5/2011

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Infection. 2010;38(4):269–73.PubMedCrossRef
2.
Das RR, Mathew JL, Ratho RK, Dutta S. Randomized clinical trial comparing hepatitis B vaccine administered by 0, 6, and 14 week versus 6, 10, and 14 week schedule in healthy infants. J Trop Pediatr. 2009;55:328–31.PubMedCrossRef
3.
del Canho R, Grosheide PM, Voogd M, Huisman WM, Heijtink RA, Schalm SW. Immunogenicity of 20 micrograms of recombinant DNA hepatitis B vaccine in healthy neonates: a comparison of three different vaccination schemes. J Med Virol. 1993;41:30–4.PubMedCrossRef
4.
Bassily S, Kotkat A, Gray G, Hyams KC, Brown FM, Imam IZ, Arthur R. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates. Am J Trop Med Hyg. 1995;53:419–22.PubMed
5.
Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006;21(4):299–305.PubMedCrossRef
6.
Polat S, Camurdan AD, Aksakal N, Agladioglu S, Beyazova U, Sahin F, Atak A, Er A. Evaluation of perinatal and intrafamilial hepatitis B prevention programmes in a well child clinic: 9-year follow-up study in Turkey. Trans R Soc Trop Med Hyg. 2011;105(4):220–5.PubMedCrossRef
7.
Akcam FZ, Uskun E, Avsar K, Songur Y. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey. Int J Infect Dis. 2009;13(2):274–84.PubMedCrossRef
8.
Altinbas S, Erdogan M, Danişman N. The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet. 2010;281(2):371.PubMedCrossRef
9.
Araz NC, Dikensoy E. Seroprevalence of hepatitis B among pregnant women in southern Turkey. J Pak Med Assoc. 2011;61(2):176–7.PubMed
10.
Turkish Ministry of Health Unpublished surveillance data. Turkish Ministry of Health, Istanbul; 2011.
Metadata
Title
Immunogenicity of two different hepatitis B vaccine schedules
Authors
S. Y. Agladioglu
U. Beyazova
A. D. Camurdan
F. Sahin
A. Atak
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 5/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0133-5

Other articles of this Issue 5/2011

Infection 5/2011 Go to the issue

Editorial

Community-onset bacteremia may be an ominous sign

Clinical and Epidemiological Study

Evaluation of potential biomarkers for the discrimination of bacterial and viral infections

Brief Report

Clostridium difficile infection: monoclonal or polyclonal genesis?

Clinical and Epidemiological Study

Outcomes of post-cataract surgery endophthalmitis referred to a tertiary center from local hospitals in the south of China

Case Report

Yokenella regensburgei in an immunocompromised host: a case report and review of the literature

Clinical and Epidemiological Study

Excess mortality from seasonal influenza is negligible below the age of 50 in Israel: implications for vaccine policy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits